Is Boston Scientific (BSX) One of the Best Healthcare AI Stocks to Buy Now?

Boston Scientific Corporation (NYSE:BSX) is one of the best healthcare AI stocks to buy now. On December 12, TD Cowen reaffirmed a Buy rating on Boston Scientific Corporation (NYSE:BSX) and kept a $115 price target. The firm went a step further to name Boston Scientific their “Best Idea for 2026.”

TD Cowen called Boston Scientific “the most attractive growth story in the medical devices sector.” The firm said this view is backed by confidence in the company’s long-range plan for more than 10% organic sales growth annually, 50 basis points of yearly operating margin expansion, and double-digit EPS growth. The analysts expect Boston Scientific to keep up double-digit organic revenue growth into 2026, even with tougher year-over-year comparisons ahead.

What sets Boston Scientific apart from peers, noted TD Cowen, is a proven history of strong double-digit earnings growth. The firm said this justifies higher valuation multiples due to its “scarcity value”; that is, few companies can match this reliable high growth. And key drivers include standout products like Farapulse (for atrial fibrillation treatment) and Watchman (for stroke prevention).

In a different update, on November 18, Boston Scientific participated in the 7th Annual Wolfe Research Healthcare Conference. During the event, senior management engaged in a fireside chat discussion centered on the company’s innovation pipeline, market expansion strategies, and performance in key growth areas, particularly electrophysiology. A major highlight was the strong adoption of the Farapulse pulsed field ablation (PFA) system. Management projected that the system’s US market penetration will exceed 50% by the end of 2025. For the Watchman left atrial appendage closure device, the discussion addressed historical trials like CLOSURE, noting limitations from older device generations and post-procedure regimens.

Boston Scientific Corporation (NYSE:BSX) develops medical devices used in cardiology, endoscopy, neuromodulation, and urology. The company applies machine learning, natural language processing, and computer vision to enhance medical imaging, predictive analytics for patient management, and remote monitoring.

While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Consumer Goods Stocks Billionaires Are Quietly Buying and Goldman Sachs Penny Stocks: Top 12 Stock Picks.

Disclosure: None. This article is originally published at Insider Monkey.